throbber
Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 1 of 12
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE WESTERN DISTRICT OF TEXAS
`WACO DIVISION
`
`FINTIV, INC.,
`
`Plaintiff,
`
`v.
`
`APPLE INC.,
`
`Defendant.
`
`Civil Action No. 6:21-cv-00926-ADA
`
`APPLE’S OPPOSED EMERGENCY MOTION FOR A CONTINUANCE
`OR, IN THE ALTERNATIVE, A STAY PENDING MANDAMUS
`
`WEST\296081809.2
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 2 of 12
`
`Apple respectfully moves to continue the current trial setting by four months due to (1)
`
`the unavailability of essential Apple witnesses and (2) surging COVID cases in the region, which
`
`has led to a critical lack of hospital capacity. Given the urgency of this motion, Apple requests
`
`that the Court order expedited briefing, with Fintiv’s response due by Friday, September 17,
`
`2021. Apple waives its right to a reply and respectfully requests a hearing on Monday,
`
`September 20, 2021, or as soon as thereafter as the Court is available.
`
`I.
`
`INTRODUCTION
`
`On September 9, 2021, the Court sua sponte transferred this case from Austin to Waco
`
`and kept the scheduled trial date of October 4, 2021. The Court’s decision to transfer the case
`
`less than a month before trial, while COVID cases are surging in the region, will deprive Apple
`
`of essential witnesses and unnecessarily risk the health and safety of everyone involved. On the
`
`other hand, a four-month continuance will not prejudice Fintiv, a non-practicing entity, and
`
`should allow the case to proceed safely in Austin, without witness conflicts and where Apple has
`
`invested significant resources preparing for trial.
`
`First, a continuance is necessary because trying this case in Waco in October 2021 may
`
`deprive Apple of two of its most critical witnesses—Mohammad Khan, a Bay Area-based prior
`
`art inventor of the VivoTech system, and Apple’s technical expert Henry Dreifus. Mr. Dreifus is
`
`serving as an expert witness in a case pending in the Eastern District of Texas that is also set for
`
`trial on October 4, and Judge Gilstrap recently denied the defendant’s motion for a continuance
`
`that would have permitted Mr. Dreifus to testify in both cases, finding that “the trial date for this
`
`case has been set for close to a year, while Fintiv’s trial date was rescheduled just six months
`
`ago.” Ex. A. Mr. Dreifus cannot attend both trials at once, so Apple risks not being able to call
`
`its technical expert at trial if the other trial takes precedence. And although Mr. Khan, a key
`
`third party prior art witness, previously agreed to attend trial in Austin if it were held in February
`
`WEST\296081809.2
`
`1
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 3 of 12
`
`or March 2022 (see Ex. B), he more recently told Apple (through his counsel) that he does not
`
`want to travel to Waco, both because of the additional travel inconvenience and because of the
`
`surge in COVID cases in Waco and elsewhere in the region. Apple faces the real risk of losing
`
`both an expert and a prior art fact witness if trial is held in Waco in October 2021.
`
`Second, a continuance is necessary to allow the current surge of COVID cases, and the
`
`resulting lack of hospital beds, to subside. The Court has previously recognized the difficulty of
`
`preparing for a patent trial during the pandemic: “The Court recognizes that preparing for a
`
`patent trial can be an arduous task in the best of times and is obviously much more difficult when
`
`mobility has been severely restricted by the Government.” Ex. C, Standing Order dated April 9,
`
`2020. Here, the difficulties in preparing for trial have been compounded by a short notice
`
`transfer to a different city with additional logistical challenges, including locating suitable office
`
`space in Waco where social distancing can be maintained. In March 2020, the Court invited the
`
`parties to seek to postpone trials where it “may cause a person to travel or act contrary to official
`
`guidance or precautions regarding the COVID-19 virus.” Ex. D, Standing Order dated March
`
`12, 2020. And the Court recently indicated that it was willing to move this trial to 2022:
`
`If both sides on this case told me right now that they want to
`postpone the trial until 2022, for example, that will be fine with me
`as well. Again, it’d have to be by agreement. But if you said that,
`then I can go about my business and be rescheduling things for that
`week now. And so it’s not that big a problem. I’ll just fill it with
`hearings or do something else.
`
`Ex. E, 8/23/21 Hr’g Tr. at 6. In response to the Court’s inquiry, Apple proposed either February
`
`or March 2022, when Apple and its witnesses are available for trial. Apple respectfully submits
`
`that, consistent with Court’s recognition of the difficulties in preparing for trial in a pandemic, a
`
`brief continuance is necessary to preserve Apple’s due process rights and to ensure the health
`
`and safety of everyone involved.
`
`WEST\296081809.2
`
`2
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 4 of 12
`
`II.
`
`AN OCTOBER TRIAL IN WACO LIKELY WILL DEPRIVE APPLE OF
`ESSENTIAL WITNESSES
`
`If the Court proceeds with trial in Waco in October, two critical Apple witnesses are
`
`likely to be unavailable—a key third-party prior art fact witness, Mohammad Khan, and Apple’s
`
`technical expert Henry Dreifus. Not being able to present these key witnesses live at trial would
`
`violate Apple’s due process rights. Due process protects the “right to a full and fair opportunity
`
`to litigate an issue,” Hardy v. Johns-Manville Sales Corp., 681 F.2d 334, 338 (5th Cir. 1982),
`
`and “to present evidence and argument on the contested facts and legal issues framed by the
`
`answer to the complaint,” Thompson v. Madison Cty. Bd. of Ed., 476 F.2d 676, 678 (5th Cir.
`
`1973). And even if it were possible for these witnesses to testify remotely, this Court has noted
`
`that “the ability to compel live trial testimony is crucial for evaluating a witnesses’ testimony.”
`
`10Tales, Inc. v. Tik-Tok, Inc., No. 6:20-CV-00810-ADA, 2021 WL 2043978, at *3 (W.D. Tex.
`
`May 21, 2021), citing Ayala v. Ruiz, 973 F.2d 411, 419 (5th Cir. 1992) (emphasis added).
`
`A.
`
`A Key Prior Art Witness, Mohammad Khan, Likely Will Not Attend Trial if
`the Case Proceeds in Waco.
`
`Apple intends to call Mohammad Khan, a third-party witness who lives and works in the
`
`Bay Area, to testify about the VivoTech prior art system, which he created. Among other things,
`
`Mr. Khan will establish that the VivoTech system was in public use in the United States prior to
`
`the critical date of the ’125 patent and will explain how the VivoTech system worked at the
`
`relevant time. His testimony is critical to Apple’s defense of this case.
`
`Apple has identified Mr. Khan as a “will call” witness and estimated his trial testimony at
`
`75 minutes, the second longest estimate among Apple’s expected witnesses. Mr. Khan
`
`previously stated he was “willing to fly to Austin and testify at the trial if it were to be held in
`
`late February or early March of next year.” Ex. B, Khan Letter. After learning of the re-transfer
`
`order, Mr. Khan told Apple (through his retained counsel) that he has serious reservations about
`
`WEST\296081809.2
`
`3
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 5 of 12
`
`testifying in Waco given the additional travel inconvenience to Waco and the surging COVID
`
`cases in McLennan County and elsewhere in the region.1 Because Mr. Khan is a third party who
`
`lives and works in the Bay Area, Apple cannot compel him to testify. However, a continuance
`
`will allow the current COVID surge to subside and will allow Mr. Khan to testify in Austin,
`
`where he has previously stated he is willing to travel in February or March 2022.
`
`B.
`
`Apple’s Technical Expert, Mr. Dreifus, Currently Has a Trial Conflict With
`the October 4 Setting.
`
`Mr. Dreifus is Apple’s technical expert and is expected to offer critical testimony on,
`
`among other things, Apple’s noninfringement and invalidity defenses. Mr. Dreifus is an
`
`eminently qualified expert, the author of “Smart Cards: A Guide to Building and Managing
`
`Smart Card Applications,” and the inventor of U.S. Patent No. 4,575,621, one of the early
`
`patents on smart cards. He will testify (among other things) that the accused Apple products do
`
`not infringe the asserted claims of the ’125 patent and that the asserted claims are invalid based
`
`on multiple prior art references. Apple has indicated that Mr. Dreifus’ direct examination at trial
`
`will last roughly 90 minutes, longer than any other Apple witness.
`
`Mr. Dreifus also is scheduled to testify at a trial set for October 4, 2021 in a case pending
`
`before Judge Gilstrap in the Eastern District of Texas. In an order dated September 8, 2021,
`
`Judge Gilstrap stated he was unwilling to accommodate Mr. Dreifus’ conflict with this trial
`
`setting. See Ex. A. Judge Gilstrap stated that if the trial conflict persists, Mr. Dreifus would
`
`1 As of September 15, 2021, McLennan County’s COVID case counts are at 134.7 per 100,000
`residents, compared to 45.6 per 100,000 residents in Travis County. Furthermore, 100 percent of
`ICU beds are filled in McLennan County, compared to 95 percent of ICU beds filled in Travis
`County. See Ex. G, McLennan County and Travis County, COVID Act Now Tracker, at 1, 7
`(COVID case counts for McLennan and Travis Counties, respectively); id. at 4, 10 (percentage
`of ICU beds filled in McLennan and Travis Counties, respectively) (updated September 15,
`2021).
`
`WEST\296081809.2
`
`4
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 6 of 12
`
`have to testify by deposition. Id. (“If the witness does not honor his prior commitment, he may
`
`appear by deposition.”). Until Apple received Judge Gilstrap’s September 8 order, Apple had
`
`understood this trial conflict was avoidable because (1) until recently Judge Gilstrap had up to
`
`six trials set for October 4, and (2) even today, he has at least two cases scheduled for trial on
`
`that day, including one case with a lower case number than Mr. Dreifus’ case.
`
`If the trial conflict is not resolved, Judge Gilstrap’s proposed solution (appearing by
`
`deposition) is not workable. Mr. Dreifus will need to attend most, if not all, of the trial in this
`
`case to observe opening statements, the testimony of Fintiv’s technical expert Dr. Shamos, and
`
`the testimony of the Apple engineers who will explain how the accused products operate.
`
`Moreover, Mr. Dreifus’ deposition testimony does not cover all issues on which he will testify at
`
`trial. A continuance will preserve Apple’s due process right to fully and fairly present its
`
`defenses through Mr. Dreifus live at trial.
`
`III.
`
`AN OCTOBER TRIAL IN WACO WILL UNNECESSARILY RISK THE
`HEALTH AND SAFETY OF EVERYONE INVOLVED IN THE TRIAL
`
`Apple understands the Court has safely conducted trials during the COVID pandemic and
`
`does not make this continuance request lightly. However, circumstances have changed
`
`dramatically in the past several months. With the emergence of the Delta variant, COVID cases
`
`have spiked, with McLennan County seeing record new cases and hospitalizations. Ex. F,
`
`“Hospitalizations, Active Cases Set Records as COVID-19 Cases Surge in McLennan County,”
`
`Waco Tribune, September 2, 2021. As of today, hospitals in and around Waco are full or nearly
`
`full, and ICU beds are 100 percent full. See Ex. G at 1-6.
`
`Beyond the obvious risks associated with interstate travel and gathering groups together
`
`during a pandemic, the current lack of hospital capacity creates added risk for anyone involved in
`
`the upcoming trial who may need medical care, whether COVID-related or not. In contrast,
`
`WEST\296081809.2
`
`5
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 7 of 12
`
`current forecasts indicate that the Delta surge is likely to subside over the next few months,
`
`which should also lead to a decrease in hospitalizations. See Center for Disease Control, Covid-
`
`19 Forecasts, https://www.cdc.gov/coronavirus/2019-ncov/science/forecasting/forecasts-
`
`cases.html. This is consistent with statements from Dr. Anthony Fauci, the nation’s top
`
`infectious disease expert, who has indicated the United States could be approaching normalcy
`
`once again by Spring 2022. See Ex. H, “US Could Control COVID by Spring 2022 if More
`
`People Get Shots,” Reuters, August 24, 2021.
`
`Given the current forecast that COVID cases will be on the decline by Spring 2022, this
`
`should create a much safer environment for trial in four months. Therefore, based on the
`
`significant risks associated with proceeding to trial in Waco in early October when cases are still
`
`dangerously high, Apple submits that a brief continuance is warranted for the health and safety
`
`of everyone involved.
`
`IV.
`
`A CONTINUANCE WILL NOT PREJUDICE FINTIV
`
`A four-month continuance will not prejudice Fintiv, a non-practicing entity that is
`
`seeking money damages in the form of a reasonable royalty and did not plead a request for
`
`injunctive relief in its operative complaint.2 See NFC Tech. LLC v. HTC Am., Inc., No. 2:13-cv-
`
`1058-WCB, 2015 WL 1069111, at *2-3 (E.D. Tex. Mar. 11, 2015) (finding no prejudice because
`
`“monetary relief will be sufficient” for a non-competitor); see also ActiveVideo Networks, Inc. v.
`
`Verizon Commc’ns, Inc., 694 F.3d 1312, 1338 (Fed. Cir. 2012) (lack of direct competition is a
`
`substantial basis for denying a permanent injunction). Indeed, “the Federal Circuit has held, ‘[a]
`
`stay will not diminish the monetary damages to which [the plaintiff] will be entitled if it succeeds
`
`2 Fintiv’s Motion for Leave to File a Third Amended Complaint, ECF No. 139, is pending.
`
`WEST\296081809.2
`
`6
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 8 of 12
`
`in its infringement suit—it only delays realization of those damages and delays any potential
`
`injunctive remedy.” CyWee Grp. Ltd. v. Samsung Elecs. Co., 2:17-CV-00140-WCB-RSP, 2019
`
`WL 11023976, at *4 (E.D. Tex. Feb. 14, 2019) (Bryson, Circuit J.) (quoting VirtualAgility Inc. v.
`
`Salesforce.com, Inc., 759 F.3d 1307, 1318 (Fed. Cir. 2014)). Notably, Fintiv has agreed to trial
`
`continuances at least three times in this case. Moreover, Fintiv has not identified a compelling
`
`reason to re-transfer this case on very short notice so it can be tried during a COVID surge.
`
`In contrast, the prejudice to Apple is significant. In addition to the witness availability
`
`issues described above, Apple (and presumably Fintiv) have invested significant resources to
`
`prepare for trial in Austin, which the Court has noted is a valid consideration. Ex. E, 8/23/21
`
`Hr’g Tr. at 7 (“And I know there are looming expenses for hotels and everything else that you
`
`have to book.”). Among other things, Apple has already incurred significant expenses reserving
`
`hotel rooms and other logistical support in Austin. Given the late notice of the shift to Waco,
`
`much of this investment will be forfeited. Trial in Austin also meant that Apple and its counsel
`
`could utilize their counsel’s ample office space near the Austin courthouse for pretrial and trial
`
`preparations, where social distancing can and will be implemented. Now Apple must scramble
`
`on short notice to try to find and secure suitable office space in Waco, which will come at
`
`additional cost and may compromise Apple’s ability to socially distance as warranted by the
`
`current COVID surge. On the other hand, a short continuance will provide the time necessary to
`
`fully prepare for trial, including providing more time for the parties to adjust their trial
`
`presentations based on the Court’s rulings on pending summary judgment and Daubert motions,
`
`among other things.
`
`WEST\296081809.2
`
`7
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 9 of 12
`
`V.
`
`IN THE ALTERNATIVE, THE COURT SHOULD GRANT A STAY PENDING
`RESOLUTION OF APPLE’S FORTHCOMING MANDAMUS PETITION
`
`If the Court denies a continuance, Apple alternatively requests a stay of the re-transfer
`
`order until the Federal Circuit resolves Apple’s petition for writ of mandamus, which Apple is
`
`filing on September 15, 2021. The petition seeks vacatur of the re-transfer order, which Apple
`
`respectfully contends is in conflict with In re Intel Corp., 841 F. App’x 192 (Fed. Cir. 2020).
`
`Apple’s stay request is governed by a four-factor test, and each factor strongly favors a stay.
`
`First, Apple’s petition will make “a strong showing” of likely success on the merits. Nken v.
`
`Holder, 556 U.S. 418, 426 (2009). Under Intel, district courts must invoke “appropriate statutory
`
`authority,” such as detailed findings under 28 U.S.C. § 1404(a). 841 F. App’x at 194-95. The
`
`re-transfer order cites no statutory authority (see Dkt. 386 at 1-2), so mandamus is warranted for
`
`the same reasons as in Intel. Second, Apple will be “irreparably injured absent a stay.” Nken,
`
`556 U.S. at 426. If the Court conducts a trial in Waco in early October, the damage that Apple’s
`
`petition seeks to avoid “will . . . already be done.” In re Lloyd’s Reg. N. Am., Inc., 780 F.3d 283,
`
`289-90 (5th Cir. 2015) (citation omitted). Third, a stay will not “substantially injure” Fintiv
`
`(Nken, 556 U.S. at 426), because Fintiv does not practice the asserted patent and does not
`
`compete with Apple. See In re Morgan Stanley, 417 F. App’x 947, 950 (Fed. Cir. 2011).
`
`Fourth, the “public interest” favors a stay (Nken, 556 U.S. at 426), because awaiting the Federal
`
`Circuit’s decision would lessen the risks from the current surge in COVID cases.
`
`VI.
`
`CONCLUSION
`
`For the foregoing reasons, Apple respectfully requests a four-month continuance so that
`
`trial can be conducted during a time when (1) Apple can present all of its trial witnesses live at
`
`trial, and (2) it is likely to be much safer for all involved.
`
`Dated: September 15, 2021
`
`Respectfully submitted,
`
`WEST\296081809.2
`
`8
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 10 of 12
`
`/s/ John M. Guaragna
`John M. Guaragna
`Texas Bar No. 24043308
`Zachary Loney (Pro Hac Vice)
`Texas Bar No. 24092714
`DLA PIPER LLP (US)
`303 Colorado, Suite 3000
`Austin, TX 78701
`Telephone: (512) 457-7000
`Facsimile: (512) 457-7001
`john.guaragna@us.dlapiper.com
`
`Mark D. Fowler (Pro Hac Vice)
`DLA PIPER LLP (US)
`2000 University Avenue
`East Palo Alto, California 94303-2214
`Telephone: (650) 833-2000
`Facsimile: (650) 833-2001
`Sean C. Cunningham (Pro Hac Vice)
`CA Bar No. 98895
`Erin Gibson (Pro Hac Vice)
`CA Bar No. 229305
`DLA PIPER LLP (US)
`401 B Street, Suite 1700
`San Diego, CA 92101-4297
`Telephone: 619.699.2700
`Fax: 619.699.2701
`sean.cunningham@dlapiper.com
`erin.gibson@dlapiper.com
`Paul Steadman (Pro Hac Vice)
`Stephanie Lim (Pro Hac Vice)
`DLA PIPER LLP (US)
`444 West Lake Street, Ste. 900
`Chicago, IL 60606
`Telephone: 312.368.4000
`J. Stephen Ravel
`State Bar No. 16584975
`KELLY HART & HALLMAN LLP
`303 Colorado, Suite 2000
`Austin, TX 78701
`Telephone: 512.495.6329
`Facsimile: 512.495.6401
`steve.ravel@kellyhart.com
`Harry L. Gillam, Jr.
`State Bar No. 07921800
`GILLAM & SMITH, LLP
`303 S. Washington Ave.
`Marshall, Texas 75670
`
`WEST\296081809.2
`
`9
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 11 of 12
`
`Telephone: 903.934.8450
`Facsimile: 903.934.9257
`gil@gillamsmithlaw.com
`Attorneys for Defendant Apple Inc.
`
`WEST\296081809.2
`
`10
`
`

`

`Case 6:21-cv-00926-ADA Document 394 Filed 09/15/21 Page 12 of 12
`
`CERTIFICATE OF CONFERENCE
`Pursuant to Local Rule 7(g), I certify that on September 15, 2021, counsel for Defendant
`
`Apple contacted counsel for Plaintiff regarding the relief sought in the foregoing motion.
`
`Plaintiff did not agree to the relief requested therein.
`
`/s/ John M. Guaragna
`John M. Guaragna
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that on this 15th day of September 2021, all counsel of record
`
`who are deemed to have consented to electronic service are being served with a copy of this
`
`document by electronic mail.
`
`/s/ John M. Guaragna
`John M. Guaragna
`
`WEST\296081809.2
`
`11
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket